o3mega+ think
o3mega+ think, licence 80004436: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Other names
- omega3+ THINK
- Licence holder
- Genuine Health Inc.
- NPN or DIN-HM
- 80004436
- Status
- Active licence
- Licence date
- 6 November 2007
- Revision date
- 16 December 2024
- Form
- Gélule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Huile de poisson Source : Hareng Potency : 100.0 mg EPA | 625.0 mg | Not calculated |
| Huile de poisson Source : Huile de corps d'anchois, sardine et maquereau Potency : 100.0 mg EPA | 625.0 mg | Not calculated |
| Huile de poisson Source : Hareng Potency : 250.0 mg DHA | Not specified | Not calculated |
| Huile de poisson Source : Huile de corps d'anchois, sardine et maquereau Potency : 250.0 mg DHA | Not specified | Not calculated |
Non-medicinal ingredients
Gélatine, Mélange de concentré de tocophérol, Huile de romarin, Glycérine
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adolescentes | Not specified | minimum: 1.0 Gélule ; maximum: 7.0 Gélule | Not specified |
| Adolescentes | Not specified | minimum: 1.0 Gélule ; maximum: 5.0 Gélule | Not specified |
| Enfants | Not specified | minimum: 1.0 Gélule ; maximum: 4.0 Gélule | Not specified |
| Adultes | Not specified | minimum: 1.0 Gélule ; maximum: 8.0 Gélule | Not specified |
Uses authorised in Canada
Text supplied in English because no French text is available.
DHA is a key Omega-3 fatty acid that supports cognitive function and maintenance of the brain in people of all ages. At 1-8 Capsules: Source of omega-3 fatty acid for the maintenance of good health. Source of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) for the maintenance of good health. Helps support cognitive health and/or brain function. At 1-5 Capsules: Helps support the development of the brain, eyes and nerves in children up to 12 years of age.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Source
Official Health Canada record, licence 80004436
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
Has the product changed? Photograph the packaging.